Molbio Diagnostics Ltd
Q1 FY27, unaudited
- Revenue
- ₹399.38 Cr
- Profit after tax
- ₹56.63 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | — |
|---|---|---|---|
| Revenue from operations | 399.38 | — | — |
| Other income | 1.37 | — | — |
| Total income | 400.75 | — | — |
| Employee benefit expense | 24.76 | — | — |
| Finance costs | 8.66 | — | — |
| Depreciation & amortisation | 8.42 | — | — |
| Total expenses | 324.82 | — | — |
| Profit before tax | 75.92 | — | — |
| Tax expense | 19.30 | — | — |
| Profit after tax | 56.63 | — | — |
| Total comprehensive income | 56.56 | — | — |
| Earnings per share, basic | ₹5.02 | — |
|---|---|---|
| Earnings per share, diluted | ₹5.02 | — |
Q1 FY27 — unaudited, from the company’s filing with NSE. Source
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Q1 FY27Molbio Diagnostics reported consolidated Q1 FY27 revenue from operations of ₹408 crores, EBITDA of ₹104 crores at a 25% margin, and profit after tax of ₹52.7 crores. Management said the company sold 164 devices and 62.4 lakh kits during the quarter, with export revenue of around ₹67 crores including a catch-up of deferrals from Q4 FY26 due to the situation in the Gulf. Management also discussed R&D investment, capacity utilization, the OptraScan and Prognosys subsidiaries, and provided full-year revenue and EBITDA guidance for FY27.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.
Filings
12 shown · 13 published by the exchange
12 Sept 2026
Transcript09 Sept 2026
08 Sept 2026
08 Sept 2026
Presentation07 Sept 2026
Filing07 Sept 2026
05 Sept 2026
Board meeting05 Sept 2026
02 Sept 2026
01 Sept 2026
27 Aug 2026
20 Aug 2026
Insider trading
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 12 Sept 2026.